Paper39559293
Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis.
Ding Z and 5 others. Noncoding RNA Res, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis. Papers, record 39559293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39559293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27125352 | From melanocytes to melanomas. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27125352 | PubMed |
| 2 | 34791419 | lncRNAfunc: a knowledgebase of lncRNA function in human cancer. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/34791419 | PubMed |
| 3 | 30882958 | Phosphatase inhibitor PPP1R11 modulates resistance of human T cells toward Treg-mediated suppression of cytokine expression. | J Leukoc Biol | 2019 | https://conductscience.org/library/papers/30882958 | PubMed |
| 4 | 35129375 | Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanoma. | Future Oncol | 2022 | https://conductscience.org/library/papers/35129375 | PubMed |
| 5 | 33464299 | LNCcation: lncRNA localization and function. | J Cell Biol | 2021 | https://conductscience.org/library/papers/33464299 | PubMed |
| 6 | 34145432 | Noncoding RNA therapeutics - challenges and potential solutions. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/34145432 | PubMed |
| 7 | 26358722 | ceRNA in cancer: possible functions and clinical implications. | J Med Genet | 2015 | https://conductscience.org/library/papers/26358722 | PubMed |
| 8 | 32029601 | The biology, function, and biomedical applications of exosomes. | Science | 2020 | https://conductscience.org/library/papers/32029601 | PubMed |
| 9 | 29290805 | Exosome Theranostics: Biology and Translational Medicine. | Theranostics | 2018 | https://conductscience.org/library/papers/29290805 | PubMed |
| 10 | 28475890 | Metabolic Instruction of Immunity. | Cell | 2017 | https://conductscience.org/library/papers/28475890 | PubMed |
| 11 | 25724326 | Exosome and exosomal microRNA: trafficking, sorting, and function. | Genomics Proteomics Bioinformatics | 2015 | https://conductscience.org/library/papers/25724326 | PubMed |
| 12 | 32429485 | Current Molecular Markers of Melanoma and Treatment Targets. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32429485 | PubMed |
| 13 | 34406447 | Significance of lncRNA abundance to function. | Mamm Genome | 2022 | https://conductscience.org/library/papers/34406447 | PubMed |
| 14 | 24566916 | Regulation of immune responses by extracellular vesicles. | Nat Rev Immunol | 2014 | https://conductscience.org/library/papers/24566916 | PubMed |
| 15 | 33588426 | CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours. | Nature | 2021 | https://conductscience.org/library/papers/33588426 | PubMed |
| 16 | 27805901 | RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity. | Elife | 2016 | https://conductscience.org/library/papers/27805901 | PubMed |
| 17 | 32759948 | Exosomes: key players in cancer and potential therapeutic strategy. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32759948 | PubMed |
| 18 | 30089911 | Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. | Nature | 2018 | https://conductscience.org/library/papers/30089911 | PubMed |
| 19 | 13679896 | Molecular biology: microRNA is here to stay. | Nature | 2003 | https://conductscience.org/library/papers/13679896 | PubMed |
| 20 | 34509219 | Immune checkpoint inhibitors in melanoma. | Lancet | 2021 | https://conductscience.org/library/papers/34509219 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42500571 | Epigenetic Modulators and Immunotherapy in Malignant Melanoma. | Oncol Res | 2026 | https://conductscience.org/library/papers/42500571 | PubMed |
| 42491964 | lncRNA HOTAIR in Cancer: Recent Advances and Critical Perspectives on Molecular Mechanisms. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42491964 | PubMed |
| 42108449 | From guardians to traitors: molecular mechanisms of tumor-induced T cell betrayal. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42108449 | PubMed |
| 41992768 | Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/41992768 | PubMed |
| 41737608 | Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | https://conductscience.org/library/papers/41737608 | PubMed |
| 41550841 | Mechanistic roles of long non-coding RNAs in gastric cancer therapy resistance. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/41550841 | PubMed |
| 40678154 | Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: A prognostic and therapeutic biomarker in breast cancer. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/40678154 | PubMed |
| 40282449 | Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282449 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| GZMB | 3002 | PubTator's text mining | https://conductscience.org/library/genes/3002 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| LINC01214 | 101928022 | PubTator's text mining | https://conductscience.org/library/genes/101928022 | NCBI Gene |
| MIR4492 | 100616376 | PubTator's text mining | https://conductscience.org/library/genes/100616376 | NCBI Gene |
| PPP1R11 | 6992 | PubTator's text mining | https://conductscience.org/library/genes/6992 | NCBI Gene |
| SPATA2 | 9825 | PubTator's text mining | https://conductscience.org/library/genes/9825 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39559293
GET https://conductscience.org/api/papers/v1/39559293/references?page=2